CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Successful Remission of Recurrent Anaphylaxis after Omalizumab Administration in a Patient with Systemic Mastocytosis
Hongran Moon, Hee Joon Jang, Choon Geun Lee, Young-Chan Kim, Shin Hye Yoo, Dong Soon Lee, Hye-Ryun Kang
Korean J Med. 2018;93(1):68-73.   Published online 2018 February 1    DOI: https://doi.org/10.3904/kjm.2018.93.1.68

Excel Download

Successful Remission of Recurrent Anaphylaxis after Omalizumab Administration in a Patient with Systemic Mastocytosis
The Korean Journal of Medicine. 2018;93(1):68-73   Crossref logo
Link1 Link2 Link3

ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis
Allergy. 2008;63(3):376-378   Crossref logo
Link1

Omalizumab monotherapy for bee sting and unprovoked “anaphylaxis” in a patient with systemic mastocytosis and undetectable specific IgE
Annals of Allergy, Asthma & Immunology. 2010;104(6):537-539   Crossref logo
Link1 Link2

Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
Allergy. 2017;73(1):230-238   Crossref logo
Link1 Link2

Occult bone marrow mastocytosis presenting as recurrent systemic anaphylaxis
Journal of Allergy and Clinical Immunology. 2003;111(2):S206   Crossref logo
Link1 Link2

Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient
Allergy. 2009;65(7):926-927   Crossref logo
Link1

Systemic mastocytosis: evolving lessons from large patient registry datasets
American Journal of Hematology. 2016;91(7):654-655   Crossref logo
Link1 Link2

Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome
Annals of Allergy, Asthma & Immunology. 2014;113(1):115-116   Crossref logo
Link1 Link2

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis
Allergy. 2009;65(8):1058-1059   Crossref logo
Link1

Use of Omalizumab to Achieve Successful Desensitization After Oxaliplatin Anaphylaxis
Journal of Allergy and Clinical Immunology. 2012;129(2):AB103   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Med has participated in CrossRef Text and Data Mining service since September 11, 2015.